Ryan L. Davis

4.0k total citations · 1 hit paper
85 papers, 2.3k citations indexed

About

Ryan L. Davis is a scholar working on Molecular Biology, Neurology and Genetics. According to data from OpenAlex, Ryan L. Davis has authored 85 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 18 papers in Neurology and 15 papers in Genetics. Recurrent topics in Ryan L. Davis's work include Mitochondrial Function and Pathology (17 papers), Parkinson's Disease Mechanisms and Treatments (15 papers) and Financial Markets and Investment Strategies (14 papers). Ryan L. Davis is often cited by papers focused on Mitochondrial Function and Pathology (17 papers), Parkinson's Disease Mechanisms and Treatments (15 papers) and Financial Markets and Investment Strategies (14 papers). Ryan L. Davis collaborates with scholars based in Australia, United States and New Zealand. Ryan L. Davis's co-authors include Carolyn M. Sue, Jin‐Sung Park, Kishore R. Kumar, Michal Lubomski, Mark J. Cowley, Christina Liang, Andrew Holmes, Jannik Prasuhn, Stephen O. Brennan and Shen‐Yang Lim and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Financial Economics and Neurology.

In The Last Decade

Ryan L. Davis

81 papers receiving 2.3k citations

Hit Papers

Mitochondrial Dysfunction in Parkinson’s Disease: New Mec... 2018 2026 2020 2023 2018 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Mitochondrial Dysfunction in Parkinson’s Disease: New Mechanistic Insights and Therapeutic Perspectives
    2018 416 citations Jin‐Sung Park, Ryan L. Davis et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ryan L. Davis Australia 28 1.1k 540 327 289 240 85 2.3k
Mária Judit Molnár Hungary 24 992 0.9× 377 0.7× 220 0.7× 279 1.0× 262 1.1× 142 1.9k
Zhaoxia Wang China 27 1.5k 1.5× 380 0.7× 367 1.1× 396 1.4× 251 1.0× 224 3.0k
Irfan Qureshi United States 27 2.1k 2.0× 139 0.3× 204 0.6× 262 0.9× 441 1.8× 85 3.0k
Kishore R. Kumar Australia 23 726 0.7× 882 1.6× 255 0.8× 647 2.2× 240 1.0× 95 1.9k
Pei‐Chun Chen Taiwan 27 1.2k 1.1× 234 0.4× 306 0.9× 510 1.8× 81 0.3× 51 2.4k
Andreas Plaitakis Greece 31 1.2k 1.1× 345 0.6× 441 1.3× 973 3.4× 345 1.4× 79 2.9k
Fei Yin China 28 1.2k 1.2× 181 0.3× 187 0.6× 451 1.6× 577 2.4× 141 2.6k
Jana Vandrovcová United Kingdom 27 1.0k 1.0× 921 1.7× 742 2.3× 315 1.1× 360 1.5× 54 2.7k
Yunliang Wang China 25 1.0k 1.0× 125 0.2× 156 0.5× 190 0.7× 188 0.8× 104 1.9k
Masayuki Kaneko Japan 33 1.6k 1.6× 312 0.6× 623 1.9× 378 1.3× 287 1.2× 98 3.6k

Countries citing papers authored by Ryan L. Davis

Since Specialization
Citations

This map shows the geographic impact of Ryan L. Davis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryan L. Davis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryan L. Davis more than expected).

Fields of papers citing papers by Ryan L. Davis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryan L. Davis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryan L. Davis. The network helps show where Ryan L. Davis may publish in the future.

Co-authorship network of co-authors of Ryan L. Davis

This figure shows the co-authorship network connecting the top 25 collaborators of Ryan L. Davis. A scholar is included among the top collaborators of Ryan L. Davis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryan L. Davis. Ryan L. Davis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Davis, Ryan L., Karl Ng, Roula Ghaoui, et al.. (2025). Long-read sequencing for diagnosis of genetic myopathies. BMJ Neurology Open. 7(1). e000990–e000990. 1 indexed citations
2.
Davis, Ryan L., et al.. (2024). Clinical drivers of hospitalisation in patients with mitochondrial diseases. BMJ Neurology Open. 6(1). e000717–e000717.
3.
Davis, Ryan L., et al.. (2024). Genetic Testing of Movements Disorders: A Review of Clinical Utility. Tremor and Other Hyperkinetic Movements. 14(1). 2–2. 4 indexed citations
4.
Xu, Xiangnan, Michal Lubomski, Andrew Holmes, et al.. (2023). NEMoE: a nutrition aware regularized mixture of experts model to identify heterogeneous diet-microbiome-host health interactions. Microbiome. 11(1). 51–51. 2 indexed citations
5.
Davis, Ryan L., Todd G. Griffith, Bonnie Van Ness, & Robert Van Ness. (2023). Modern OTC market structure and liquidity: The tale of three tiers. Journal of Financial Markets. 64. 100815–100815. 1 indexed citations
6.
7.
Davis, Ryan L., Kishore R. Kumar, Clare Puttick, et al.. (2022). Use of Whole-Genome Sequencing for Mitochondrial Disease Diagnosis. Neurology. 99(7). e730–e742. 32 indexed citations
8.
Lubomski, Michal, Xiangnan Xu, Andrew Holmes, et al.. (2022). The Gut Microbiome in Parkinson’s Disease: A Longitudinal Study of the Impacts on Disease Progression and the Use of Device-Assisted Therapies. Frontiers in Aging Neuroscience. 14. 875261–875261. 28 indexed citations
9.
Davis, Ryan L., et al.. (2022). Low disease risk and penetrance in Leber hereditary optic neuropathy. The American Journal of Human Genetics. 110(1). 166–169. 15 indexed citations
10.
Besnier, Marie, Christine Yu, Katharine A. Kott, et al.. (2021). Patient Endothelial Colony-Forming Cells to Model Coronary Artery Disease Susceptibility and Unravel the Role of Dysregulated Mitochondrial Redox Signalling. Antioxidants. 10(10). 1547–1547. 10 indexed citations
11.
Davis, Ryan L., et al.. (2020). New diagnostic pathways for mitochondrial disease. 21 indexed citations
12.
Lubomski, Michal, Ryan L. Davis, & Carolyn M. Sue. (2020). Depression in Parkinson's disease: Perspectives from an Australian cohort. Journal of Affective Disorders. 277. 1038–1044. 29 indexed citations
13.
Davis, Ryan L., et al.. (2019). 136 Mitochondrial biomarkers in parkinson’s disease. Journal of Neurology Neurosurgery & Psychiatry. 90(12). e38.2–e38. 1 indexed citations
14.
Kim, Aryun, Kishore R. Kumar, Ryan L. Davis, et al.. (2019). Increased Diagnostic Yield of Spastic Paraplegia with or Without Cerebellar Ataxia Through Whole-Genome Sequencing. The Cerebellum. 18(4). 781–790. 27 indexed citations
15.
Darrah, Erika, Jon T. Giles, Ryan L. Davis, et al.. (2018). Autoantibodies to Peptidylarginine Deiminase 2 Are Associated With Less Severe Disease in Rheumatoid Arthritis. Frontiers in Immunology. 9. 2696–2696. 35 indexed citations
16.
Menezes, Minal, Yiran Guo, Jianguo Zhang, et al.. (2015). Mutation in mitochondrial ribosomal protein S7 (MRPS7) causes congenital sensorineural deafness, progressive hepatic and renal failure and lactic acidemia. Human Molecular Genetics. 24(8). 2297–2307. 58 indexed citations
17.
Riley, Lisa G., Joëlle Rudinger‐Thirion, Klaus Schmitz‐Abe, et al.. (2015). LARS2 Variants Associated with Hydrops, Lactic Acidosis, Sideroblastic Anemia, and Multisystem Failure. JIMD Reports. 28. 49–57. 39 indexed citations
18.
19.
Davis, Ryan L. & Carolyn M. Sue. (2011). The Genetics of Mitochondrial Disease. Seminars in Neurology. 31(5). 519–530. 26 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mária Judit Molnár Breakdown of academic impact, for papers by Zhaoxia Wang Breakdown of academic impact, for papers by Irfan Qureshi Breakdown of academic impact, for papers by Kishore R. Kumar Breakdown of academic impact, for papers by Pei‐Chun Chen Breakdown of academic impact, for papers by Andreas Plaitakis Breakdown of academic impact, for papers by Fei Yin Breakdown of academic impact, for papers by Jana Vandrovcová Breakdown of academic impact, for papers by Yunliang Wang Breakdown of academic impact, for papers by Masayuki Kaneko
Rankless by CCL
2026